Patients Divided Over Alzheimer鈥檚 Drug: Is It a 鈥楻isk I鈥檓 Willing to Take鈥 or Just a 鈥楳agic Pill鈥?
Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer鈥檚 disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.